Last updated on November 2017

RTOG 1016: Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer


Brief description of study

RTOG 1016: Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer

Detailed Study Description

For more information please visit: http://clinicaltrials.gov/ct2/show/NCT01302834?term=NCT01302834&rank=1

Clinical Study Identifier: TX2815

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Patricia Green

Memorial University Medical Center
Savannah, GA USA
  Connect »